Business Context and Reporting Period
This Form 8-K is a current report filed by ChromaDex Corporation (not Niagen Bioscience, Inc.) on June 6, 2016. The filing reports a corporate governance event regarding the expansion of the Board of Directors.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is strictly a notice of a board appointment.
Material Changes
- Board Expansion: The Board of Directors increased its size from six to seven members.
- New Appointment: William Smithburg was appointed as a new director.
- Qualifications: Mr. Smithburg brings extensive experience as a former CEO and Chairman of The Quaker Oats Company and current board service at Barry-Wehmiller Company.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It references a press release (Exhibit 99.1) issued on June 7, 2016, regarding the appointment.
Investor Verification Checklist
- Verify the exact date of Mr. Smithburg's effective board membership.
- Review the full press release (Exhibit 99.1) for additional context on the appointment.
- Confirm the current total number of directors on the Board (now seven).
- Note that this filing does not impact the company's financial position or operational results.